STOCK TITAN

IMRN Furnishes Emerging Growth Conference Presentation as Exhibit 99.2

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Immuron Limited furnished a Form 6-K reporting that it published two public notices to the Australian Securities Exchange titled "Emerging Growth Conference Presentation". The filing states that a copy of the presentation is attached to the Form 6-K as Exhibit 99.2.

The Form 6-K clarifies that this submission and the attached exhibit are furnished for information only and are not deemed to be "filed" under the U.S. Exchange Act, and therefore are not incorporated by reference into other securities filings except by explicit reference. The report is signed on behalf of the company by its Company Secretary.

Positive

  • Disclosure of investor presentation via Exhibit 99.2 improves transparency about the company’s external communications
  • Formal furnishing to the Australian Securities Exchange and the SEC demonstrates regulatory compliance

Negative

  • No financial data or material transactions are included, so the filing provides limited information for investors
  • Document is furnished, not "filed", which limits its incorporation by reference and may constrain legal reliance on the disclosure

Insights

TL;DR: Routine investor presentation disclosure with no financial figures; limited immediate impact on valuation.

The filing simply furnishes an investor presentation as Exhibit 99.2 and does not include operating results, guidance, material transactions, or financial metrics. As such, there is no direct financial data to update revenue, earnings, or cash flow models. The disclosure preserves transparency about investor outreach but contains no new numerical information that would change near-term financial forecasts.

TL;DR: Procedural disclosure; legal effect is limited because the document is furnished, not "filed."

The Form 6-K explicitly states it is furnished and not deemed "filed" for Exchange Act purposes, limiting the exhibit's use in incorporation-by-reference into other filings. This is a standard control on legal effect and suggests the company is providing informational materials without creating broader filing obligations. The signature by the Company Secretary indicates authorized corporate submission.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of August 2025

 

Commission File Number: 001-38104

 

IMMURON LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ☐       No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 

 

 

 

IMMURON LIMITED

 

EXPLANATORY NOTE

 

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on August 18, 2025 titled:

 

-Emerging Growth Conference Presentation

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

1

 

 

EXHIBITS

 

Exhibit
Number
  Description
99.2   Emerging Growth Conference Presentation

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  IMMURON LIMITED
     
Date: August 13, 2025 By: /s/ Phillip Hains
    Phillip Hains
    Company Secretary

 

3

 

FAQ

What did Immuron (IMRN) disclose in this Form 6-K?

The company disclosed that it published two public notices titled "Emerging Growth Conference Presentation" and attached the presentation as Exhibit 99.2 to the Form 6-K.

Is the presentation attached as an exhibit to the Form 6-K?

Yes. The filing states the investor presentation is included as Exhibit 99.2.

Where were the public notices published?

The public notices were published to the Australian Securities Exchange as stated in the Form 6-K.

Does this Form 6-K include financial results or material transactions for IMRN?

No. The Form 6-K and attached exhibit do not contain earnings data, financial tables, or material transaction disclosures.

Who signed the Form 6-K for Immuron?

The Form 6-K is signed on behalf of the company by Phillip Hains, Company Secretary.
Immuron Ltd

NASDAQ:IMRN

View IMRN Stock Overview

IMRN Rankings

IMRN Latest News

IMRN Latest SEC Filings

IMRN Stock Data

6.39M
8.17M
Biotechnology
Healthcare
Link
Australia
Carlton